Islet-brain1/c-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease

Molecular Psychiatry

Volumn 8, Issue 4, 2003, Pages 413-422

  Helbecque, N ^a   Abderrhamani, A ^b   Meylan, L ^b   Riederer, B ^b   Mooser, V ^b   Miklossy, J ^b   Delplanque, J ^a   Boutin, P ^a   Nicod, P ^b   Haefliger, J A ^b   Cottel, D ^a   Amouyel, P ^a   Froguel, P ^a,c   Waeber, G ^b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Apoptosis; Human genetics; LRP; MAPK; Transcription IB1 JIP 1

Indexed keywords

C JUN N TERMINAL KINASE INTERACTING PROTEIN 1; KINESIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PROTEIN; PROTEIN PRECURSOR; REELIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; BRAIN NERVE CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRANCE; GENE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MITOGEN ACTIVATED PROTEIN KINASE 8IP1 GENE; MOUSE; NONHUMAN; POPULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN VARIANT; RISK FACTOR; STRESS; BRAIN CORTEX; CONFOCAL MICROSCOPY; NEUROFILAMENT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALZHEIMER DISEASE; AUTOPSY; BASE SEQUENCE; BRAIN; CARRIER PROTEINS; COGNITION; DNA PRIMERS; FRANCE; HUMANS; NEUROBLASTOMA; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

EID: 0038025377     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001344     Document Type: Article

References (49)

1. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000; 103: 239-252.
2. Davis RJ, Signal transduction by the c-Jun N-terminal kinase. Biochem Soc Symp 1999; 64: 1-12.
3. Harper SJ, LoGrasso P. Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal 2001; 13: 299-310.
4. Whitmarsh AJ, Davis RJ. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem Sci 1998; 23: 481-485.
5. Dickens M, Rogers JS, Cavanagh J et al. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 1997; 277: 693-696.
6. Bonny C, Nicod P, Waeber G. IB1, a JIP-1-related nuclear protein present in insulin-secreting cells. J Biol Chem 1998; 273: 1843-1846.
7. Mooser V, Maillard A, Bonny C et al. Genomic organization, fine-mapping, and expression of the human islet-brain 1 (IB1)/c-Jun-amino-terminal kinase interacting protein-1 (JIP-1) gene. Genomics 1999; 55: 202-208.
8. Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 1998; 281: 1671-1674.
9. Harding TC, Xue L, Bienemann A et al. Inhibition of JNK by overexpression of the JNL binding domain of JIP-1 prevents apoptosis in sympathetic neurons. J Biol Chem. 2001; 276: 4531-4534.
10. Tawadros T, Formenton A, Dudler J et al. The scaffold protein IB1/JIP-1 controls the activation of JNK in rat stressed urothelium. J Cell Sci 2002; 115: 385-393.
11. Whitmarsh AJ, Kuan CY, Kennedy NJ et al. Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes Dev 2001; 15: 2421-2432.
12. Thompson NA, Haefliger JA, Senn A et al. Islet-brain1/JNK-interacting protein-1 is required for early embryogenesis in mice. J Biol Chem 2001; 276: 27745-27748.
13. Stockinger W, Brandes C, Fasching D et al. The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2. J Biol Chem 2000; 275: 25625-25632.
14. Gotthardt M, Trommsdorff M, Nevitt MF et al. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J Biol Chem 2000; 275: 25616-25624.
15. Meyer D, Liu A, Margolis B. Interaction of c-Jun amino-terminal kinase interacting protein-1 with p190 rhoGEF and its localization in differentiated neurons. J Biol Chem 1999; 274: 35113-35118.
16. Verhey KJ, Meyer D, Deehan R et al. Cargo of kinesin identified as jip scaffolding proteins and associated signaling molecules. J Cell Biol 2001; 152: 959-970.
17. Matsuda S, Yasukawa T, Homma Y et al. c-Jun n-terminal kinase (jnk)-interacting protein-1b/islet-brain-1 scaffolds alzheimer's amyloid precursor protein with jnk. J Neurosci 2001; 21: 6597-6607.
18. Taru H, Kirino Y, Suzuki T. Differential roles of JIP scaffold proteins in the modulation of amyloid precursor protein metabolism. J Biol Chem 2002; 277: 27567-27574.
19. Lambert JC, Mann D, Goumidi L et al. A FE65 polymorphism associated with risk of developing sporadic late- onset alzheimer's disease but not with Abeta loading in brains. Neurosci Lett 2000; 293: 29-32.
20. Baum L, Chen L, Ng HK et al. Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese. Neurosci Lett 1998; 247: 33-36.
21. Lendon CL, Talbot CJ, Craddock NJ et al. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 1997; 222: 187-190.
22. Lambert JC, Chartier-Harlin MC, Cottel D et al. Is the LDL receptor-related protein involved in Alzheimer's disease? Neurogenetics. 1999; 2: 109-113.
23. Herz J, Beffert U. Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Nat Rev Neurosci 2000; 1: 51-58.
24. Hollenbach E, Ackermann S, Hyman BT, Rebeck GW. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology 1998; 50: 1905-1907.
25. Pellet JB, Haefliger JA, Staple JK et al. Spatial, temporal and subcellular localization of islet-brain 1 (IB1), a homologue of JIP-1, in mouse brain. Eur J Neurosci 2000; 12: 621-632.
26. Hayashi T, Sakai K, Sasaki C, Zhang WR, Warita H, Abe K. c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion. Neurosci Lett 2000; 284: 195-199.
27. Gillardon F, Spranger M, Tiesler C, Hossmann KA. Expression of cell death-associated phospho-c-Jun and p53-activated gene 608 in hippocampal CA1 neurons following global ischemia. Brain Res Mol Brain Res 1999; 73: 138-143.
28. Bonny C, Oberson A, Steinmann M, Schorderet DF, Nicod P, Waeber G. IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. J Biol Chem 2000; 275: 16466-16472.
29. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes. 2001; 50: 77-82.
30. Barr RK, Kendrick TS, Bogoyevitch MA. Identification of the critical features of a small peptide inhibitor of JNK activity. J Biol Chem 2002; 277: 10987-10997.
31. Xia XG, Harding T, Weller M, Bieneman A, Uney JB, Schulz JB. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 2001; 98: 10433-10438.
32. Waeber G, Delplanque J, Bonny C et al. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet 2000; 24: 291-295.
33. Amouyel P, Richard F, Cottel D, Amant C, Codron V, Helbecque N. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci Lett 1996; 217: 203-205.
34. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
35. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239-259.
36. Abderrahmani A, Steinmann M, Plaisance V et al. The transcriptional repressor REST determines the cell-specific expression of the human MAPK8IP1 gene encoding IB1 (JIP-1). Mol Cell Biol 2001; 21: 7256-7267.
37. Riederer BM, Mourton-Gilles C, Frey P, Delacourte A, Probst A. Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease. J Neurocytol 2001; 30: 145-158.
38. Buee-Scherrer V, Condamines O, Mourton-Gilles C et al. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Res Mol Brain Res 1996; 39: 79-88.
39. Delacourte A, David JP, Sergeant N et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 1999; 52: 1158-1165.
40. Hashimoto M, Hsu LJ, Rockenstein E, Takenouchi T, Mallory M, Masliah E. alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J Biol Chem 2002; 277: 11465-11472.
41. Trommsdorff M, Gotthardt M, Hiesberger T et al. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 1999; 97: 689-701.
42. Howell BW, Herz J. The LDL receptor gene family: signaling functions during development. Curr Opin Neurobiol 2001; 11: 74-81.
43. Willnow TE, Nykjaer A, Herz J. Lipoprotein receptors: new roles for ancient proteins. Nat Cell Biol 1999; 1: E157-E162.
44. Helbecque N, Richard F, Cottel D, Neuman E, Guez D, Amouyel P. The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population. Alzheimer Dis Assoc Disord 1998; 12: 368-371.
45. Sanchez-Guerra M, Combarros O, Infante J et al. Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease. Neurosci Lett 2001; 316: 17-20.
46. Clement K, Ruiz J, Cassard-Doulcier AM et al. Additive effect of A->G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord 1996; 20: 1062-1066.
47. Rosmond R, Chagnon M, Bouchard C, Bjorntorp P. A polymorphism in the regulatory region of the corticotropin-releasing hormone gene in relation to cortisol secretion, obesity, and gene-gene interaction. Metabolism 2001; 50: 1059-1062.
48. Kang DE, Pietrzik CU, Baum L et al. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest 2000; 106: 1159-1166.
49. Bennett BL, Sasaki DT, Murray BW et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001; 98: 13681-13886.